Therapeutic targeting of nuclear protein import in pathological cell conditions

Pharmacological Reviews

Volumn 61, Issue 3, 2009, Pages 358-372

  Chahine, Mirna N ^a   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (3,5 DIACETYLPHENYL)AMINO 6 METHYLPYRIMIDINE; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ITI 002; KETONE DERIVATIVE; METHYL GROUP; NUCLEAR PROTEIN; PEPTIDE DERIVATIVE; PHOSPHOTRANSFERASE INHIBITOR; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; SN 50; TACROLIMUS; THIAMINE DISULFIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL TRANSPORT; CELL VIABILITY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; NUCLEAR IMPORT; NUCLEAR PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VIROTHERAPY; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NUCLEAR PROTEINS; VIRUS DISEASES;

EID: 70349664476     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.108.000620     Document Type: Article

References (136)

1. Adam EJ and Adam SA (1994) Identification of cytosolic factors required for nuclear location sequence-mediated binding to the nuclear envelope. J Cell Biol 125:547-555.
2. Agudo D, Gómez-Esquer F, Martínez-Arribas F, Núñez-Villar MJ, Pollán M, and Schneider J (2004) Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 109:717-720. (Pubitemid 38405619)
3. Al-Abed Y, Dubrovsky L, Ruzsicka B, Seepersaud M, and Bukrinsky M (2002) Inhibition of HIV-1 nuclear import via schiff base formation with arylene bis-(methyl ketone) compounds. Bioorg Med Chem Lett 12:3117-3119.
4. Alvisi G, Rawlinson SM, Ghildyal R, Ripalti A, and Jans DA (2008) Regulated nucleocytoplasmic trafficking of viral gene products: a therapeutic target? Biochim Biophys Acta 1784:213-227.
5. Aronov O, Horowitz AT, Gabizon A, Fuertes MA, Pérez JM, and Gibson D (2004) Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues. Bioconjug Chem 15:814-823. (Pubitemid 38981956)
6. Basel-Vanagaite L, Muncher L, Straussberg R, Pasmanik-Chor M, Yahav M, Rainshtein L, Walsh CA, Magal N, Taub E, Drasinover V, et al. (2006) Mutated nup62 causes autosomal recessive infantile bilateral striatal necrosis. Ann Neurol 60:214-222. (Pubitemid 44182396)
7. Behrens P, Brinkmann U, Fogt F, Wernert N, and Wellmann A (2001) Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res 21:2413-2417. (Pubitemid 33054403)
8. Behrens P, Brinkmann U, and Wellmann A (2003) CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8:39-44. (Pubitemid 36133136)
9. Bonifaci N, Moroianu J, Radu A, and Blobel G (1997) Karyopherin beta2 mediates nuclear import of a mRNA binding protein. Proc Natl Acad Sci U S A 94:5055-5060. (Pubitemid 27214735)
10. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, and Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97:1715-1722. (Pubitemid 26105480)
11. Brinkmann U, Gallo M, Polymeropoulos MH, and Pastan I (1996) The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res 6:187-194. (Pubitemid 126664298)
12. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, and Stevenson M (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669. (Pubitemid 23350541)
13. Chahine MN, Blackwood DP, Dibrov E, Richard MN, and Pierce GN (2009) Oxidized LDL affects smooth muscle cell growth through MAPK-mediated actions on nuclear protein import. J Mol Cell Cardiol 46:431-441.
14. Chai YC, Howe PH, DiCorleto PE, and Chisolm GM (1996) Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem 271:17791-17797.
15. Chen LF and Greene WC (2003) Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81:549-557.
16. Chen P, Cameron R, Wang J, Vallis KA, and Reilly RM (2003) Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. J Nucl Med 44:1469-1478. (Pubitemid 39663362)
17. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, and Brent R (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380:548-550. (Pubitemid 26110646)
18. Colas P, Cohen B, Ko Ferrigno P, Silver PA, and Brent R (2000) Targeted modification and transportation of cellular proteins. Proc Natl Acad Sci U S A 97:13720-13725.
19. Costantini DL, Hu M, and Reilly RM (2008) Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications. Cancer Biother Radiopharm 23:3-24. (Pubitemid 351304218)
20. Crabtree GR and Olson EN (2002) NFAT signaling: choreographing the social lives of cells. Cell 109 (Suppl):S67-S79.
21. Cronshaw JM and Matunis MJ (2003) The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci U S A 100:5823-5827. (Pubitemid 36576892)
22. Czubryt MP, Austria JA, and Pierce GN (2000) Hydrogen peroxide inhibition of nuclear protein import is mediated by the mitogen-activated protein kinase, ERK2. J Cell Biol 148:7-16.
23. Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, Dürst M, Klinkhammer-Schalke M, et al. (2006) Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin Cancer Res 12:3950-3960. (Pubitemid 44078080)
24. Dubrovsky L, Ulrich P, Nuovo GJ, Manogue KR, Cerami A, and Bukrinsky M (1995) Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. Mol Med 1:217-230.
25. Enninga J, Levy DE, Blobel G, and Fontoura BM (2002) Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295:1523-1525. (Pubitemid 34174007)
26. Ertl PF and Powell KL (1992) Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J Virol 66:4126-4133.
27. Fang X, Gaudette D, Furui T, Mao M, Estrella V, Eder A, Pustilnik T, Sasagawa T, Lapushin R, Yu S, et al. (2000) Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann N Y Acad Sci 905:188-208. (Pubitemid 30255418)
28. Faustino RS, Nelson TJ, Terzic A, and Perez-Terzic C (2007a) Nuclear transport: target for therapy. Clin Pharmacol Ther 81:880-886.
29. Faustino RS, Stronger LN, Richard MN, Czubryt MP, Ford DA, Prociuk MA, Dibrov E, and Pierce GN (2007b) RanGAP-mediated nuclear protein import in vascular smooth muscle cells is augmented by lysophosphatidylcholine. Mol Pharmacol 71:438-445. (Pubitemid 46147910)
30. Faustino RS, Cheung P, Richard MN, Dibrov E, Kneesch AL, Deniset JF, Chahine MN, Lee K, Blackwood D, and Pierce GN (2008) Ceramide regulation of nuclear protein import. J Lipid Res 49:654-662.
31. Finlay DR, Newmeyer DD, Price TM, and Forbes DJ (1987) Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores. J Cell Biol 104:189-200.
32. Force T, Krause DS, and Van Etten RA (2007) Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 7:332-344. (Pubitemid 46652481)
33. Friedler A, Zakai N, Karni O, Broder YC, Baraz L, Kotler M, Loyter A, and Gilon C (1998) Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells. Biochemistry 37:5616-5622. (Pubitemid 28241946)
34. Gama-Carvalho M and Carmo-Fonseca M (2001) The rules and roles of nucleocytoplasmic shuttling proteins. FEBS Lett 498:157-163. (Pubitemid 32539194)
35. Gasiorowski JZ and Dean DA (2003) Mechanisms of nuclear transport and interventions. Adv Drug Deliv Rev 55:703-716.
36. Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, and Fojo T (2000) p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol 2:709-717. (Pubitemid 30768153)
37. Glushakova S, Grivel JC, Suryanarayana K, Meylan P, Lifson JD, Desrosiers R, and Margolis L (1999) Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo. J Virol 73:3968-3974. (Pubitemid 29189841)
38. Goldenberg DM (2002) Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med 43:693-713. (Pubitemid 34507123)
39. Goldfarb DS, Corbett AH, Mason DA, Harreman MT, and Adam SA (2004) Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol 14:505-514.
40. Gould VE, Orucevic A, Zentgraf H, Gattuso P, Martinez N, and Alonso A (2002) Nup88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum Pathol 33:536-544. (Pubitemid 34747874)
41. Greber UF, Webster P, Weber J, and Helenius A (1996) The role of the adenovirus protease on virus entry into cells. EMBO J 15:1766-1777. (Pubitemid 26119212)
42. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, and Helenius A (1997) The role of the nuclear pore complex in adenovirus DNA entry. EMBO J 16:5998-6007. (Pubitemid 27427295)
43. Guan T, Müller S, Klier G, Panté N, Blevitt JM, Haner M, Paschal B, Aebi U, and Gerace L (1995) Structural analysis of the p62 complex, an assembly of O-linked glycoproteins that localizes near the central gated channel of the nuclear pore complex. Mol Biol Cell 6:1591-1603.
44. Gustin KE and Sarnow P (2001) Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 20:240-249.
45. Gustin KE and Sarnow P (2002) Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J Virol 76:8787-8796. (Pubitemid 34864074)
46. Haffar O, Dubrovsky L, Lowe R, Berro R, Kashanchi F, Godden J, Vanpouille C, Bajorath J, and Bukrinsky M (2005) Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein. J Virol 79:13028-13036. (Pubitemid 41433222)
47. Hallhuber M, Burkard N, Wu R, Buch MH, Engelhardt S, Hein L, Neyses L, Schuh K, and Ritter O (2006) Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circ Res 99:626-635. (Pubitemid 44401454)
48. Harcourt BH, Sanchez A, and Offermann MK (1999) Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol 73:3491-3496. (Pubitemid 29135747)
49. Hearps AC and Jans DA (2006) HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism. Biochem J 398:475-484.
50. Heit JJ (2007) Calcineurin/NFAT signaling in the beta-cell: from diabetes to new therapeutics. Bioessays 29:1011-1021. (Pubitemid 47522841)
51. Heit JJ, Karnik SK, and Kim SK (2006) Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 22:311-338.
52. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, and Kim SK (2006) Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443:345-349. (Pubitemid 44435154)
53. Holmes-McNary M and Baldwin AS Jr (2000) Chemopreventive properties of transresveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 60:3477-3483. (Pubitemid 30482167)
54. Horwitz MS and Loeb LA (1990) Structure-function relationships in Escherichia coli promoter DNA. Prog Nucleic Acid Res Mol Biol 38:137-164.
55. Hu T, Guan T, and Gerace L (1996) Molecular and functional characterization of the p62 complex, an assembly of nuclear pore complex glycoproteins. J Cell Biol 134:589-601. (Pubitemid 26269133)
56. Huang S, Robinson JB, Deguzman A, Bucana CD, and Fidler IJ (2000) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60:5334-5339. (Pubitemid 30761236)
57. Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, and Wesierska-Gadek J (2001) Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366-372. (Pubitemid 32240814)
58. Invernizzi P, Selmi C, Ranftler C, Podda M, and Wesierska-Gadek J (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298-310. (Pubitemid 41254577)
59. Jans DA (1994) Nuclear signaling pathways for polypeptide ligands and their membrane receptors? FASEB J 8:841-847.
60. Kassis AI (2003) Cancer therapy with Auger electrons: are we almost there? J Nucl Med 44:1479-1481.
61. Kau TR and Silver PA (2003) Nuclear transport as a target for cell growth. Drug Discov Today 8:78-85. (Pubitemid 36139901)
62. Kau TR, Way JC, and Silver PA (2004) Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 4:106-117.
63. Kehlenbach RH, Dickmanns A, Kehlenbach A, Guan T, and Gerace L (1999) A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. J Cell Biol 145:645-657. (Pubitemid 29240845)
64. Kerkelä R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ, et al. (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12:908-916. (Pubitemid 44175142)
65. Kiani A, Rao A, and Aramburu J (2000) Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12:359-372. (Pubitemid 30953960)
66. Kim IS, Kim DH, Han SM, Chin MU, Nam HJ, Cho HP, Choi SY, Song BJ, Kim ER, Bae YS, et al. (2000) Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53. J Biol Chem 275:23139-23145.
67. Kiriyama T, Hirano M, Asai H, Ikeda M, Furiya Y, and Ueno S (2008) Restoration of nuclear-import failure caused by triple A syndrome and oxidative stress. Biochem Biophys Res Commun 374:631-634.
68. Kodiha M, Tran D, Qian C, Morogan A, Presley JF, Brown CM, and Stochaj U (2008) Oxidative stress mislocalizes and retains transport factor importin-alpha and nucleoporins Nup153 and Nup88 in nuclei where they generate high molecular mass complexes. Biochim Biophys Acta 1783:405-418.
69. Kodiha M, Chu A, Matusiewicz N, and Stochaj U (2004) Multiple mechanisms promote the inhibition of classical nuclear import upon exposure to severe oxidative stress. Cell Death Differ 11:862-874. (Pubitemid 39139745)
70. Köhler M, Speck C, Christiansen M, Bischoff FR, Prehn S, Haller H, Görlich D, and Hartmann E (1999) Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol Cell Biol 19:7782-7791. (Pubitemid 29493442)
71. Kondo Y, Fushikida K, Fujieda T, Sakai K, Miyata K, Kato F, and Kato M (2008) Efficient delivery of antibody into living cells using a novel HVJ envelope vector system. J Immunol Methods 332:10-17.
72. Kosugi S, Hasebe M, Entani T, Takayama S, Tomita M, and Yanagawa H (2008) Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling. Chem Biol 15:940-949.
73. Krosky PM, Baek MC, Jahng WJ, Barrera I, Harvey RJ, Biron KK, Coen DM, and Sethna PB (2003) The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol 77:7720-7727. (Pubitemid 36792768)
74. Lam MH, Thomas RJ, Loveland KL, Schilders S, Gu M, Martin TJ, Gillespie MT, and Jans DA (2002) Nuclear transport of parathyroid hormone (PTH)-related protein is dependent on microtubules. Mol Endocrinol 16:390-401. (Pubitemid 34131233)
75. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, and Corbett AH (2007) Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem 282:5101-5105. (Pubitemid 47093710)
76. Lee CH, Jeon YT, Kim SH, and Song YS (2007) NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29:19-35. (Pubitemid 46985299)
77. Leopold PL and Crystal RG (2007) Intracellular trafficking of adenovirus: many means to many ends. Adv Drug Deliv Rev 59:810-821.
78. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, and Hung MC (2006) Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 98:1570-1583. (Pubitemid 44141861)
79. Lu H and Huan C (2007) Transcription factor NFAT, its role in cancer development, and as a potential target for chemoprevention. Curr Cancer Drug Targets 7:343-353. (Pubitemid 46849239)
80. Markovics J, Glass L, and Maul GG (1974) Pore patterns on nuclear membranes. Exp Cell Res 85:443-451.
81. Marschall M, Freitag M, Suchy P, Romaker D, Kupfer R, Hanke M, and Stamminger T (2003) The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311:60-71. (Pubitemid 36794210)
82. Maul GG, Deaven LL, Freed JJ, Campbell GL, and Beçak W (1980) Investigation of the determinants of nuclear pore number. Cytogenet Cell Genet 26:175-190.
83. McBride KM, Banninger G, McDonald C, and Reich NC (2002) Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. EMBO J 21:1754-1763. (Pubitemid 34614631)
84. Meggio F and Pinna LA (2003) One-thousand-and-one substrates of protein kinase CK2? FASEB J 17:349-368. (Pubitemid 36292951)
85. Melen K, Fagerlund R, Franke J, Kohler M, Kinnunen L, and Julkunen I (2003) Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. J Biol Chem 278:28193-28200. (Pubitemid 36900019)
86. Miyamoto Y, Saiwaki T, Yamashita J, Yasuda Y, Kotera I, Shibata S, Shigeta M, Hiraoka Y, Haraguchi T, and Yoneda Y (2004) Cellular stresses induce the nuclear accumulation of importin alpha and cause a conventional nuclear import block. J Cell Biol 165:617-623. (Pubitemid 38765763)
87. Mocarski ES Jr and Kemble GW (1996) Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology 39:320-330.
88. Moffatt S, Wiehle S, and Cristiano RJ (2006) A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy. Gene therapy 13:1512-1523. (Pubitemid 44567148)
89. Moroianu J, Blobel G, and Radu A (1996) The binding site of karyopherin alpha for karyopherin beta overlaps with a nuclear localization sequence. Proc Natl Acad Sci U S A 93:6572-6576. (Pubitemid 26230349)
90. Mukherjee R, Hewett KW, Walker JD, Basler CG, and Spinale FG (1998) Changes in L-type calcium channel abundance and function during the transition to pacinginduced congestive heart failure. Cardiovasc Res 37:432-444. (Pubitemid 28166003)
91. Mukherjee R and Spinale FG (1998) L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review. J Mol Cell Cardiol 30:1899-1916. (Pubitemid 28495317)
92. Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, et al. (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118-127. (Pubitemid 46144371)
93. Nisole S and Saïb A (2004) Early steps of retrovirus replicative cycle. Retrovirology 1:9. (Pubitemid 39130586)
94. Paschal BM and Gerace L (1995) Identification of NTF2, a cytosolic factor for nuclear import that interacts with nuclear pore complex protein p62. J Cell Biol 129:925-937.
95. Petersen JM, Her LS, and Dahlberg JE (2001) Multiple vesiculoviral matrix proteins inhibit both nuclear export and import. Proc Natl Acad Sci U S A 98:8590-8595.
96. Pieper GM and Riaz-ul-Haq (1997) Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 30:528-532.
97. Pitt GS (2007) Calmodulin and CaMKII as molecular switches for cardiac ion channels. Cardiovasc Res 73:641-647.
98. Piva R, Gianferretti P, Ciucci A, Taulli R, Belardo G, and Santoro MG (2005) 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and downregulation of antiapoptotic proteins. Blood 105:1750-1758. (Pubitemid 40223699)
99. Poon IK and Jans DA (2005) Regulation of nuclear transport: central role in development and transformation? Traffic 6:173-186.
100. Popov S, Dubrovsky L, Lee MA, Pennathur S, Haffar O, aL-Abed Y, Tonge P, Ulrich P, Rexach M, Blobel G, et al. (1996) Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation. Proc Natl Acad Sci U S A 93:11859-11864.
101. Pouton CW, Wagstaff KM, Roth DM, Moseley GW, and Jans DA (2007) Targeted delivery to the nucleus. Adv Drug Deliv Rev 59:698-717.
102. Ratan R, Mason DA, Sinnot B, Goldfarb DS, and Fleming RJ (2008) Drosophila importin alpha1 performs paralog-specific functions essential for gametogenesis. Genetics 178:839-850.
103. Räty JK, Pikkarainen JT, Wirth T, and Ylä-Herttuala S (2008) Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 1:13-23.
104. Rayet B and Gélinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947.
105. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, Carbonnelle C, Volchkov VE, Nichol ST, and Basler CF (2006) Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol 80:5156-5167. (Pubitemid 43752761)
106. Reilly RM (2005) Biomolecules as targeting vehicles for in situ radiotherapy of malignancies, in Modern Biopharmaceuticals: Design, Development and Optimization (Knaeblein J, Mueller R, eds) pp 497-526, Wiley-VCH, Weinheim, Germany.
107. Ribbeck K, Lipowsky G, Kent HM, Stewart M, and Görlich D (1998) NTF2 mediates nuclear import of Ran. EMBO J 17:6587-6598. (Pubitemid 28521793)
108. Richard MN, Deniset JF, Kneesh AL, Blackwood D, and Pierce GN (2007) Mechanical stretching stimulates smooth muscle cell growth, nuclear protein import, and nuclear pore expression through mitogen-activated protein kinase activation. J Biol Chem 282:23081-23088. (Pubitemid 47311950)
109. Roth DM, Moseley GW, Glover D, Pouton CW, and Jans DA (2007) A microtubule-facilitated nuclear import pathway for cancer regulatory proteins. Traffic 8:673-686. (Pubitemid 46785150)
110. Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, and Fontoura BM (2007) Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A 104:1853-1858. (Pubitemid 46239868)
111. Sekimoto T, Imamoto N, Nakajima K, Hirano T, and Yoneda Y (1997) Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J 16:7067-7077. (Pubitemid 27520806)
112. Shoji S, Furuishi K, Ogata A, Yamataka K, Tachibana K, Mukai R, Uda A, Harano K, Matsushita S, and Misumi S (1998) An allosteric drug, o,o′-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. Biochem Biophys Res Commun 249:745-753. (Pubitemid 28441910)
113. Shu W, Chen Y, Wu Q, Li R, and Cui G (2008) Deguelin represses both the expression of nucleophosmin and some nucleoporins: Nup88 and Nup214 in Jurkat cells. Biol Pharm Bull 31:27-32.
114. Smith A, Brownawell A, and Macara IG (1998) Nuclear import of Ran is mediated by the transport factor NTF2. Curr Biol 8:1403-1406. (Pubitemid 29020151)
115. Snow CM, Senior A, and Gerace L (1987) Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J Cell Biol 104:1143-1156. (Pubitemid 17084472)
116. Sorokin AV, Kim ER, and Ovchinnikov LP (2007) Nucleocytoplasmic transport of proteins. Biochemistry (Mosc) 72:1439-1457.
117. Stewart M (2007) Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 8:195-208. (Pubitemid 46310545)
118. Takada Y, Bhardwaj A, Potdar P, and Aggarwal BB (2004) Nonsteroidal antiinflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23:9247-9258. (Pubitemid 40069695)
119. Temming K, Fretz MM, and Kok RJ (2008) Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs. Curr Mol Pharmacol 1:1-12.
120. Terry LJ, Shows EB, and Wente SR (2007) Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318:1412-1416.
121. Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB, et al. (1997) Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17:444-452. (Pubitemid 26425634)
122. van der Aa MA, Mastrobattista E, Oosting RS, Hennink WE, Koning GA, and Crommelin DJ (2006) The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm Res 23:447-459.
123. Wagstaff KM, Fan JY, De Jesus MA, Tremethick DJ, and Jans DA (2008) Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting. FASEB J 22:2232-2242.
124. Wagstaff KM, Glover DJ, Tremethick DJ, and Jans DA (2007) Histone-mediated transduction as an efficient means for gene delivery. Mol Ther 15:721-731. (Pubitemid 46431992)
125. Wellmann A, Flemming P, Behrens P, Wuppermann K, Lang H, Oldhafer K, Pastan I, and Brinkmann U (2001) High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. Int J Mol Med 7:489-494.
126. Wesierska-Gadek J, Klima A, Komina O, Ranftler C, Invernizzi P, and Penner E (2007) Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies. Ann N Y Acad Sci 1109:519-530. (Pubitemid 47511395)
127. Wesierska-Gadek J, Hohenauer H, Hitchman E, and Penner E (1995) Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis. Acta Biochim Pol 42:197-200.
128. Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, Worman HJ, Gershwin ME, Podda M, and Invernizzi P (2006) Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 43:1135-1144. (Pubitemid 43724638)
129. Wesierska-Gadek J, Klima A, Ranftler C, Komina O, Hanover J, Invernizzi P, and Penner E (2008) Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen. J Cell Biochem 104:27-37.
130. Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, et al. (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98:472-482.
131. Yaseen NR and Blobel G (1997) Cloning and characterization of human karyopherin beta3. Proc Natl Acad Sci U S A 94:4451-4456. (Pubitemid 27194262)
132. Zettler ME, Prociuk MA, Austria JA, Massaeli H, Zhong G, and Pierce GN (2003) OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am J Physiol Heart Circ Physiol 284:H644-H653. (Pubitemid 36142893)
133. Zettler ME, Prociuk MA, Austria JA, Zhong G, and Pierce GN (2004) Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins. Arterioscler Thromb Vasc Biol 24:727-732. (Pubitemid 38451611)
134. Zhang ZY, Zhao ZR, Jiang L, Li JC, Gao YM, Cui DS, Wang CJ, Schneider J, Wang MW, and Sun XF (2007) Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum. Tumour Biol 28:93-99. (Pubitemid 46328597)
135. Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, et al. (2008) Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 135:1017-1027.
136. Zhu J and McKeon F (1999) NF-AT activation requires suppression of Crm1- dependent export by calcineurin. Nature 398:256-260. (Pubitemid 29142862)